Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine
2024

Oral Paltusotine for Acromegaly Treatment

Sample size: 58 publication Evidence: high

Author Information

Author(s): Mônica R. Gadelha, Alessandra Casagrande, Christian J. Strasburger, Martin Bidlingmaier, Peter J. Snyder, Mirtha A. Guitelman, Cesar L. Boguszewski, Michael Buchfelder, Ilan Shimon, Gerald Raverot, Miklós Tóth, Emese Mezősi, Mirjana Doknic, Xiaolin Fan, David Clemmons, Peter J. Trainer, R. Scott Struthers, Alan Krasner, Beverly M. K. Biller

Primary Institution: Crinetics Pharmaceuticals, Inc.

Hypothesis

Can switching from injected somatostatin receptor ligands to oral paltusotine maintain disease control in acromegaly patients?

Conclusion

Oral paltusotine effectively maintained biochemical and symptom control in acromegaly patients previously treated with injected somatostatin receptor ligands.

Supporting Evidence

  • 83.3% of patients on paltusotine maintained IGF-I ≤1.0× ULN compared to 3.6% on placebo.
  • Paltusotine showed significant improvement in IGF-I levels and acromegaly symptoms compared to placebo.
  • Lower rates of rescue medication use were observed in the paltusotine group (6.7%) compared to placebo (60.7%).
  • Patients reported a significant reduction in acromegaly symptoms when treated with paltusotine.

Takeaway

This study shows that taking a pill called paltusotine can help people with acromegaly feel better and keep their hormone levels normal, just like getting shots.

Methodology

This was a phase 3, randomized, double-blind, placebo-controlled trial with patients switched from injected somatostatin receptor ligands to oral paltusotine for 36 weeks.

Limitations

The study only included patients with controlled acromegaly on injected SRLs, which may not represent all acromegaly patients.

Participant Demographics

{"age_mean":55.9,"sex_distribution":{"female":50,"male":50},"race_distribution":{"white":76.7,"black_or_african_american":6.7,"asian":0,"multiple_or_other":10.0,"unknown":6.7},"ethnicity":{"his":36.7,"not_his":56.7,"unknown":6.7}}

Statistical Information

Confidence Interval

95% CI, 13.73->999.99

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1210/clinem/dgae385

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication